Evaluation of antifungal activities of the essential oil and various extracts of Nigella sativa and its main component, thymoquinone against pathogenic dermatophyte strains

Journal of Medical Mycology

Volumn 24, Issue 4, 2014, Pages e155-e161

  Mahmoudvand, H ^a,b   Sepahvand, A ^c   Jahanbakhsh, S ^a,b   Ezatpour, B ^d   Ayatollahi Mousavi, S A ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Black cumin; Microsporum canis; Microsporum gypseum; Trichophyton mentagrophytes

Indexed keywords

CARVACROL; ESSENTIAL OIL; FLUCONAZOLE; KETOCONAZOLE; LONGIFOLENE; METHANOL; NIGELLA SATIVA EXTRACT; PARA CYMENE; PLANT MEDICINAL PRODUCT; THYMOQUINONE; UNCLASSIFIED DRUG; WATER; ANTIFUNGAL AGENT; BENZOQUINONE DERIVATIVE; CARAWAY OIL; PLANT EXTRACT; VEGETABLE OIL;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTHRODERMA GYPSEUM; ARTICLE; BLACK CUMIN; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DISK DIFFUSION; DRUG EFFECT; FUNGAL STRAIN; MACROPHAGE; MALE; MASS FRAGMENTOGRAPHY; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MTT ASSAY; NONHUMAN; PHYTOCHEMISTRY; SOLVENT EFFECT; TRICHOPHYTON MENTAGROPHYTES; ANIMAL; ARTHRODERMATACEAE; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; DERMATOMYCOSES; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PRECLINICAL STUDY;

ARTHRODERMA BENHAMIAE; ARTHRODERMA GYPSEUM; MICROSPORUM CANIS; MURINAE; NIGELLA SATIVA;

ANIMALS; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; BENZOQUINONES; CELLS, CULTURED; DERMATOMYCOSES; DRUG EVALUATION, PRECLINICAL; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; NIGELLA SATIVA; OILS, VOLATILE; PLANT EXTRACTS; PLANT OILS;

EID: 84916634114     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2014.06.048     Document Type: Article

References (31)

1. Abbaszadeh S., Sharifzadeh A., Shokri H., Khosravi A.R., Abbaszadeh A. Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi. J Mycol Med 2014, [pii: S1156-5233(14)00064-X, Epub ahead of print]. 10.1016/j.mycmed.2014.01.063.
2. Adams R.P. Identification of essential oil components by gas chromatography/mass spectroscopy 2004, Carol Stream, IL: Allured Publishing Corporation, Illinois, USA.
3. Agrawal R., Kharya M.D., Shrivastava R. Antimicrobial and anthelmintic activities of the essential oil of Nigella sativa Linn. Indian J Exp Biol 1979, 17:1264-1265.
4. Ali B., Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2009, 17:299-305.
5. Aljabre S.H., Randhawa M.A., Akhtar N., Alakloby O.M., Alqurashi A.M., Aldossary A. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharmacol 2005, 101:116-119.
6. Badary O.A., Al-Shabanah O.A., Nagi M.N., Al-Bekairi A.M., Almazar M.M.A. Acute and subchronic toxicity of thymoquinone in mice. Drug Develop Res 1998, 44:56-61.
7. CLSI/Clinical Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi 2002, Wayne, [Approved Standard M38-A].
8. Cowan M.M. Plant products as antimicrobial agents. Clin Microbiol Rev 1999, 12:564-582.
9. de Melo J.O., Bitencourt T.A., Fachin A.L., Cruz E.M., de Jesus H.C., Alves P.B., et al. Antidermatophytic and antileishmanial activities of essential oils from Lippia gracilis Schauer genotypes. Acta Trop 2013, 128:110-115.
10. De Pauw B.E. Is there a need for new antifungal agents?. Clin Microbiol Infect 2000, 6:23-28.
11. El Daly E.S. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin induced toxicity in rats. J Pharm Belg 1998, 53:87-95.
12. Jamalian A., Shams-Ghahfarokhi M., Jaimand K., Pashootan N., Amani A., Razzaghi-Abyaneh M. Chemical composition and antifungal activity of Matricaria recutita flower essential oil against medically important dermatophytes and soil-borne pathogens. J Med Mycol 2012, 22:308-315.
13. Keivani S., Salamat F., Emami M., Adimi P., Amin G. In vitro evaluation of the susceptibility of dermatophytic and saprophytic fungi to Pistacia vera's pericarp extract. Med Sci J Islamic Azad Univ 2006, 16:135-140.
14. Khan M.A., Ashfaq M.K., Zuberi H.S., Zuberi A.H. The in vivo antifungal activity of the aqueous extract from Nigella sativa seed. Phytother Res 2003, 17:183-186.
15. Khanna T., Zaidi F.A., Dandiya P.C. CNS and analgesic studies on Nigella sativa. Fitoterapia 1993, 5:407-410.
16. Mahmoud M.R., El-Abhar H.S., Saleh S. The effects of Nigella sativa oil against the liver damage induced by Schistosoma mansoni in mice. J Ethnopharmacol 2002, 79:1-11.
17. Mahmoudvand H., Sharifi I., Fasihi Harandi M., Shokohi M., Shakibaie M., Rezaei Riabi T., et al. Anti-leishmania effects of methotrexate (MTX) alone and incombination with meglumine antimoniate (MA) against Iranian isolate of sensitive and MA-resistant Leishmania tropica: an in-vitro assay. Asian Pac J Trop Med 2014, 412-420.
18. Mahmoudvand H., Sharififar F., Sharifi I., Ezatpour B., Fasihi Harandi M., Makki M.S., et al. In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, berberine against different leishmania species. Iran J Parasitol 2014, 9:28-36.
19. McCutcheon A.R., Ellis S.M., Hancock R.W., Tower G.N.H. Antibiotic screening of medicinal plants of the British Columbian native peoples. J Ethnopharmacol 1992, 37:213-223.
20. Morsi N.M. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 2000, 49:63-74.
21. Naeini A., Jalayer Naderi N., Shokri H. Analysis and in vitro anti-Candida antifungal activity of Cuminum cyminum and Salvadora persica herbs extracts against pathogenic Candida strains. J Med Mycol 2014, 24:13-18.
22. Nic Gabhainn S. The precision and robustness of published protocols for disc diffusion assay of anti microbial agents susceptibility. Aqua Cult 2004, 240:1-18.
23. Nilforoushzadeh M.A., Hejazi S.H., Zarkoob H., Shirani-Bidabadi L., Jaffary L. Efficacy of adding topical honey-based hydroalcoholic extract Nigella Sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime. J Skin Leishmaniasis 2010, 1:26-31.
24. Randhawa M.A., Al-Ghamdi M.S. A review of the pharmacotherapeutic effects of Nigella sativa. Pak J Med Res 2002, 41:77-83.
25. Rocha L.G., Almeida J.R., Macedo R.O., Barbosa-Filho J.M. A review of natural products with antileishmanial activity. Phytomedicine 2005, 12:514-535.
26. Salem M.L., Hossain M.S. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. Int J Immunopharmacol 2000, 22:729-740.
27. Suthar M.P., Patel P.N., Shah T.G., Patel R.K. In vitro screening of Nigella sativa seeds for antifungal activity. Int J Pharm Appl Sci 2010, 1:84-91.
28. Valadares D.G., Duarte M.C., Oliveira J.S., Chávez-Fumagalli M.A., Martins V.T., Costa L.E., et al. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Parasitol Int 2011, 60:357-363.
29. Vardar-Unlu G., Yağmuroğlu A., Unlu M. Evaluation of in vitro activity of carvacrol against Candida albicans strains. Nat Prod Res 2010, 24:1189-1193.
30. Watanabe S. Present state and future direction of topical antifungals. Jpn J Med Mycol 1999, 40:151-155.
31. Weitzman I., Summerbell R.C. The dermatophytes. Clin Microbiol Rev 1995, 8:240-259.